2016
DOI: 10.3109/1354750x.2015.1130746
|View full text |Cite
|
Sign up to set email alerts
|

Plasma concentrations of amino acid and nicotinamide metabolites in rheumatoid arthritis – potential biomarkers of disease activity and drug treatment

Abstract: This study aimed to evaluate changes in plasma amino acid and nicotinamide metabolites concentrations in rheumatoid arthritis (RA) in a search for potential biomarkers of the disease activity and the effect treatment. Analysis of plasma metabolite patterns with liquid chromatography/mass spectrometry revealed specific changes in RA as well as correlations with clinical parameters. Combined concentration parameter calculated as [aspartic acid] + [threonine] + [tryptophan] - [histidine] - [phenylalanine] offered… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
27
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 14 publications
2
27
0
Order By: Relevance
“…Amino acid profiling and metabolome analysis using mass spectrometry have been powerful analytical tools [ 7 ] for revealed associations between plasma amino acid profiles and various diseases, including cancer [ 8 10 ], obesity and glucose metabolism [ 11 14 ], end-stage liver disease [ 15 ], inflammatory bowel disease [ 16 ], depression [ 17 ], rheumatoid arthritis [ 18 ], acute dissecting aortic aneurysm [ 19 ], and aging and longevity [ 20 , 21 ]. Understanding changes in amino acid profiles may therefore be useful for early diagnosis and insight into the pathophysiological mechanisms underlying such diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Amino acid profiling and metabolome analysis using mass spectrometry have been powerful analytical tools [ 7 ] for revealed associations between plasma amino acid profiles and various diseases, including cancer [ 8 10 ], obesity and glucose metabolism [ 11 14 ], end-stage liver disease [ 15 ], inflammatory bowel disease [ 16 ], depression [ 17 ], rheumatoid arthritis [ 18 ], acute dissecting aortic aneurysm [ 19 ], and aging and longevity [ 20 , 21 ]. Understanding changes in amino acid profiles may therefore be useful for early diagnosis and insight into the pathophysiological mechanisms underlying such diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint damage with a heterogeneous course and different pathogenic mechanisms. 1 Chronic inflammation can lead to oxidative stress and consequently the formation of carbonyl, reactive carbonyl compounds, which are partly transformed into advanced glycation end products (AGEs). 2,3 Non-enzymatic glycation begins with interaction and link between the carbonyl group of a reducing sugar and an aminoterminal group of protein.…”
Section: Introductionmentioning
confidence: 99%
“…In minimal medium containing 20% heat-inactivated serum, no differences in growth were observed in heat-inactivated serum between WT KPPR1 and KPPR1Δ gltA strains (Fig 5A and 5B), and these results were replicated in non-heat-inactivated serum (S7 Fig). To determine if amino acid levels in reported in human blood are sufficient to functionally complement the loss of gltA , we tested the growth of WT KPPR1 and KPPR1Δ gltA strains in minimal medium with serum-level concentrations of glutamine, glutamate, and proline [49,50], which are higher than those measured in BALF (Table 2). Indeed, serum-level concentrations of glutamine, glutamate, and proline were able to restore growth of the KPPR1Δ gltA strain (Fig 5C and 5D).…”
Section: Resultsmentioning
confidence: 99%